Telix Stock And 2 Australian Growth Shares With High Insider Ownership

With inflation, energy prices and central bank policy all in focus, many investors are looking for companies where management is clearly aligned with shareholders and still talking about growth. That is exactly what the Fast Growing Stocks With High Insider Ownership screener aims to surface, by filtering for businesses that pair strong growth potential with optimistic outlooks from both analysts and company leadership. In this article, you will see three stocks from this screener that stand out on those criteria, so you can decide whether this kind of growth plus insider commitment approach deserves a place on your watchlist.

Overview: Predictive Discovery is an Australian gold company focused on exploring, developing and operating gold assets in West Africa, anchored by its flagship 356 square kilometer Bankan Gold project in north east Guinea and supported by producing mines at Kiniero and Nampala.

Market Cap: A$3.1b

Predictive Discovery is drawing attention because it already has two producing West African mines feeding cash into the high profile Bankan Gold project, while analysts see a path to much larger operations if development continues as planned. At the same time, the company is still loss making, with a recent quarterly loss and less than one year of cash runway, and it relies on external borrowings and equity raises, which have diluted shareholders. Add in insider selling, a very high P/B ratio and a relatively new management team, and it presents a high potential but high risk growth profile that calls for close scrutiny rather than blind enthusiasm.

Predictive Discovery’s twin producing mines feeding a flagship project create a growth story that looks powerful on the surface, but the real tension sits in the 2 key rewards and 4 important warning signs (2 are major!)

Overview: Telix Pharmaceuticals is a commercial stage biopharmaceutical company that develops and sells radiopharmaceutical products, which are radioactive drugs used to image and treat cancers so doctors can more precisely find and target tumours. Its portfolio spans approved imaging agents for prostate cancer and a broad pipeline of therapeutic and diagnostic candidates across prostate, kidney, brain and other solid tumours.

Operations: Telix generates most of its revenue from Precision Medicine at US$621.9m, with additional contributions from Manufacturing Solutions at US$245.1m and Therapeutics at US$9.3m. The United States is by far its largest geographic market at US$784.9m.

Market Cap: A$5.0b

Telix Pharmaceuticals stands out because it already has a substantial commercial imaging business while building a deep late stage pipeline in prostate, kidney and brain cancer, backed by multiple Phase 3 trials and recent partnerships such as the Regeneron collaboration. The company reports Precision Medicine momentum and has reaffirmed FY2026 revenue guidance of US$950 to US$970m. Its shares trade on a P/S that is below many biopharma peers and the company’s internal fair value estimate. At the same time, Telix is still loss making, funds operations with higher risk borrowing and faces trial, regulatory and pricing setbacks that could affect its plans. That mix of scale, pipeline potential and funding and execution risk may make Telix a company that growth focused investors choose to research further.

Telix Pharmaceuticals appears to be a commercial engine funding a late stage cancer pipeline. However, the real story lies in how the market is pricing that mix of revenue, guidance and trial risk in the analyst forecasts for Telix Pharmaceuticals

Overview: GemLife Communities Group develops, builds, owns and operates resort style land lease communities for over 50s across Australia, combining home construction, community management and leisure facilities to support active, socially connected living.

Operations: GemLife generates A$259.8m from Development and A$21.9m from Community Operations, with all A$281.7m of revenue coming from Australia.

Market Cap: A$1.6b

GemLife Communities Group is attracting attention because it pairs a long pipeline of around 8,300 homesites and a vertically integrated building model with forecasts for revenue and earnings growth relative to the wider Australian market. This is within a niche over 50s downsizer segment that already supports recurring site rental income. However, there are also challenges, including a recent one off loss of A$34.4m, high reliance on external borrowing, board turnover and a P/E that sits well above many real estate peers. When you also factor in analyst expectations for margins, a longer dated debt profile and a current price that sits below some fair value estimates, GemLife becomes a stock that growth-focused investors may want to study more closely before making up their minds.

GemLife Communities Group’s long pipeline and premium P/E suggest that the market is already pricing in a bigger story, but the real surprise sits in the 4 key rewards and 2 important warning signs (1 is major!)

The three stocks covered here are a small sample of what you can find. The full Fast Growing Stocks With High Insider Ownership results surfaced 97 more companies where growth potential and insider commitment combine into equally compelling stories in the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify and analyze the specific catalysts, insider trends and growth narratives that matter to you so you can focus on the highest conviction ideas in that list.

Take Control of Your Investment Journey

If Predictive Discovery or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen.
Once you’ve made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.
Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.
By uncovering hidden catalysts and risks early, you’ll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

New ideas can move from quiet to crowded quickly, and the strongest themes often break out before most investors notice. Tap into fresh, curated stock shortlists and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com